ZSWIM2
gene geneOn this page
Also known as MGC33890ZZZ2MEX
Summary
ZSWIM2 (zinc finger SWIM-type containing 2, HGNC:30990) is a protein-coding gene on chromosome 2q32.1, encoding E3 ubiquitin-protein ligase ZSWIM2 (Q8NEG5). E3 ubiquitin-protein ligase involved in the regulation of Fas-, DR3- and DR4-mediated apoptosis.
Predicted to enable ubiquitin protein ligase activity and zinc ion binding activity. Predicted to be involved in apoptotic process and protein polyubiquitination. Predicted to act upstream of or within positive regulation of extrinsic apoptotic signaling pathway via death domain receptors.
Source: NCBI Gene 151112 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 85 total
- GTEx eGene: eQTL in 10 tissues, sQTL in 1 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.06 (unconstrained)
- MANE Select transcript:
NM_182521 - Notable: 85 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30990 |
| Approved symbol | ZSWIM2 |
| Name | zinc finger SWIM-type containing 2 |
| Location | 2q32.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC33890, ZZZ2, MEX |
| Ensembl gene | ENSG00000163012 |
| Ensembl biotype | protein_coding |
| Entrez | 151112 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay
MANE Select: ENST00000295131
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1, TSL 5: 1
ENST00000295131, ENST00000419862, ENST00001138065
RefSeq mRNA: 1 — MANE Select: NM_182521
NM_182521
CCDS: CCDS33348
Canonical transcript exons
ENST00000295131 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001070635 | 186827475 | 186828790 |
| ENSE00001070637 | 186833946 | 186834030 |
| ENSE00001070639 | 186848966 | 186849170 |
| ENSE00001070640 | 186833120 | 186833232 |
| ENSE00001070641 | 186838959 | 186839169 |
| ENSE00001070642 | 186829727 | 186829880 |
| ENSE00001130202 | 186837306 | 186837554 |
| ENSE00001241066 | 186844717 | 186844757 |
| ENSE00003506878 | 186847719 | 186847795 |
Expression profiles
Bgee: expression breadth broad, 61 present calls, max score 88.60.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0196 / max 12.6304, expressed in 5 samples.
Highest expression (Bgee): male germ line stem cell (sensu Vertebrata) in testis, primordial germ cell in gonad, testis, sperm, adenohypophysis.
Genetic regulation across tissues (GTEx eQTL / sQTL)
ZSWIM2 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 10 tissues and its splicing (sQTL) in 1 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
11 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Testis | sqtl | 1.3e-13 | +0.61 | 2:186850731:C:T |
| Testis | eqtl | 7.3e-11 | +0.19 | 2:186852402:T:C |
| Adipose Visceral Omentum | eqtl | 2.2e-07 | -0.34 | 2:186842713:C:A |
| Cells Cultured fibroblasts | eqtl | 2.2e-07 | -0.19 | 2:186850731:C:T |
| Adipose Subcutaneous | eqtl | 1.3e-05 | -0.27 | 2:186824351:C:T |
| Pituitary | eqtl | 3.0e-04 | -0.33 | 2:186843992:C:T |
| Brain Nucleus accumbens basal ganglia | eqtl | 3.0e-04 | -0.44 | 2:186840395:A:G |
| Brain Cortex | eqtl | 5.8e-04 | -0.78 | 2:186870952:A:G |
| Brain Caudate basal ganglia | eqtl | 1.3e-03 | -0.39 | 2:186825547:C:G |
| Brain Frontal Cortex BA9 | eqtl | 1.3e-02 | -0.46 | 2:186846434:T:G |
| Brain Putamen basal ganglia | eqtl | 4.1e-02 | +0.72 | 2:187005848:A:G |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 32793 | 0.0128 | 5 |
| 32794 | 0.0069 | 3 |
Top tissues by expression
showing 100 of 222 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.60 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 66.55 | gold quality |
| left testis | UBERON:0004533 | 66.49 | gold quality |
| testis | UBERON:0000473 | 65.92 | gold quality |
| right testis | UBERON:0004534 | 65.19 | gold quality |
| sperm | CL:0000019 | 65.12 | silver quality |
| adenohypophysis | UBERON:0002196 | 56.38 | gold quality |
| pituitary gland | UBERON:0000007 | 55.59 | gold quality |
| buccal mucosa cell | CL:0002336 | 54.37 | silver quality |
| lower lobe of lung | UBERON:0008949 | 50.79 | silver quality |
| prefrontal cortex | UBERON:0000451 | 48.50 | gold quality |
| cortical plate | UBERON:0005343 | 48.33 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 46.22 | gold quality |
| hypothalamus | UBERON:0001898 | 45.69 | gold quality |
| nucleus accumbens | UBERON:0001882 | 45.53 | gold quality |
| cardia of stomach | UBERON:0001162 | 45.46 | gold quality |
| frontal cortex | UBERON:0001870 | 44.50 | gold quality |
| stromal cell of endometrium | CL:0002255 | 44.37 | gold quality |
| neocortex | UBERON:0001950 | 43.85 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| forebrain | UBERON:0001890 | 43.30 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 42.62 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| cerebral cortex | UBERON:0000956 | 42.53 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 42.24 | gold quality |
| right frontal lobe | UBERON:0002810 | 41.95 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| islet of Langerhans | UBERON:0000006 | 41.12 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| caudate nucleus | UBERON:0001873 | 41.03 | gold quality |
| brain | UBERON:0000955 | 41.00 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 40.27 | gold quality |
| jejunum | UBERON:0002115 | 40.18 | gold quality |
| placenta | UBERON:0001987 | 40.11 | gold quality |
| mammary duct | UBERON:0001765 | 40.07 | gold quality |
| cartilage tissue | UBERON:0002418 | 40.06 | gold quality |
| ventricular zone | UBERON:0003053 | 40.03 | gold quality |
| oviduct epithelium | UBERON:0004804 | 40.03 | gold quality |
| primary visual cortex | UBERON:0002436 | 40.02 | silver quality |
| mucosa of sigmoid colon | UBERON:0004993 | 39.95 | gold quality |
| occipital lobe | UBERON:0002021 | 39.94 | silver quality |
| deltoid | UBERON:0001476 | 39.83 | gold quality |
| saphenous vein | UBERON:0007318 | 39.83 | gold quality |
| parotid gland | UBERON:0001831 | 39.81 | gold quality |
| oocyte | CL:0000023 | 39.80 | gold quality |
| urethra | UBERON:0000057 | 39.80 | gold quality |
| heart right ventricle | UBERON:0002080 | 39.79 | gold quality |
| Ammon’s horn | UBERON:0001954 | 39.77 | silver quality |
| pericardium | UBERON:0002407 | 39.77 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 39.77 | gold quality |
| endothelial cell | CL:0000115 | 39.75 | gold quality |
| synovial joint | UBERON:0002217 | 39.70 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 39.68 | gold quality |
| nipple | UBERON:0002030 | 39.68 | gold quality |
| bronchial epithelial cell | CL:0002328 | 39.65 | gold quality |
| decidua | UBERON:0002450 | 39.65 | gold quality |
| penis | UBERON:0000989 | 39.64 | gold quality |
| gingiva | UBERON:0001828 | 39.64 | gold quality |
| bronchus | UBERON:0002185 | 39.64 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 39.63 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 39.60 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 39.57 | gold quality |
| superior surface of tongue | UBERON:0007371 | 39.56 | gold quality |
| pylorus | UBERON:0001166 | 39.55 | gold quality |
| renal medulla | UBERON:0000362 | 39.53 | gold quality |
| pons | UBERON:0000988 | 39.51 | gold quality |
| putamen | UBERON:0001874 | 39.50 | gold quality |
| thymus | UBERON:0002370 | 39.50 | gold quality |
| medulla oblongata | UBERON:0001896 | 39.48 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 39.47 | gold quality |
| colonic mucosa | UBERON:0000317 | 39.45 | gold quality |
| parietal pleura | UBERON:0002400 | 39.45 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 39.40 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 39.38 | gold quality |
| tongue | UBERON:0001723 | 39.37 | gold quality |
| cerebellar vermis | UBERON:0004720 | 39.37 | gold quality |
| oral cavity | UBERON:0000167 | 39.35 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 39.35 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 39.35 | silver quality |
| ventral tegmental area | UBERON:0002691 | 39.35 | gold quality |
| trachea | UBERON:0003126 | 39.33 | gold quality |
| parietal lobe | UBERON:0001872 | 39.32 | gold quality |
| vena cava | UBERON:0004087 | 39.31 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 39.27 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 39.23 | gold quality |
| visceral pleura | UBERON:0002401 | 39.23 | gold quality |
| postcentral gyrus | UBERON:0002581 | 39.23 | gold quality |
| body of tongue | UBERON:0011876 | 39.22 | gold quality |
| medial globus pallidus | UBERON:0002477 | 39.18 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.92 |
HPA expression
RNA tissue specificity: Tissue enriched
35 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Testis | tissue | 8.7 |
| Periaqueductal gray | tissue | 4.0 |
| Basal ganglia | tissue | 2.1 |
| Hippocampal formation | tissue | 1.6 |
| Septum | tissue | 1.6 |
| Amygdala | tissue | 1.5 |
| Cerebral cortex | tissue | 1.4 |
| Hypothalamus | tissue | 1.4 |
| Olfactory bulb | tissue | 1.4 |
| Insular cortex | tissue | 1.4 |
| Pons | tissue | 1.3 |
| Retrosplenial cortex | tissue | 1.3 |
| Entorhinal cortex | tissue | 1.2 |
| Somatosensory cortex | tissue | 1.2 |
| Occipital cortex | tissue | 1.2 |
| Prefrontal cortex | tissue | 1.1 |
| Cerebellum | tissue | 1.1 |
| Ventral forebrain | tissue | 1.1 |
| Retrosplenial and cingulate cortex | tissue | 1.1 |
| Temporal cortex | tissue | 1.1 |
| Corpus callosum | tissue | 1.0 |
| Motor cortex | tissue | 0.9 |
| Midbrain | tissue | 0.8 |
| Medulla oblongata | tissue | 0.8 |
| Thalamus | tissue | 0.8 |
| Putamen | tissue | 0.7 |
| Pituitary gland | tissue | 0.6 |
| Superior colliculi | tissue | 0.6 |
| Substantia nigra | tissue | 0.6 |
| Spinal cord | tissue | 0.5 |
| Nucleus accumbens | tissue | 0.2 |
| Locus coeruleus | tissue | 0.2 |
| Choroid plexus | tissue | 0.1 |
| Hippocampus | tissue | 0.1 |
| Postcentral gyrus | tissue | 0.1 |
Brain sub-regions (HPA Brain Atlas): detected in 146; highest nTPM — Dorsal hippocampus (1.6), Subiculum (1.4), Ventral hippocampus (1.4), White matter (1.0), Arcuate nucleus (0.6).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting ZSWIM2 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
showing 30 of 36 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-454-3P | 99.91 | 74.01 | 1925 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-7856-5P | 99.75 | 69.99 | 2901 |
| HSA-MIR-6073 | 99.60 | 70.36 | 793 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-6083 | 99.47 | 68.73 | 2393 |
| HSA-MIR-6080 | 99.43 | 69.43 | 373 |
| HSA-MIR-3140-5P | 99.39 | 69.04 | 1136 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-5190 | 99.15 | 67.76 | 1234 |
| HSA-MIR-4464 | 98.95 | 67.73 | 820 |
| HSA-MIR-4748 | 98.95 | 67.53 | 810 |
| HSA-MIR-138-2-3P | 98.91 | 68.33 | 1643 |
| HSA-MIR-6074 | 98.89 | 69.64 | 2187 |
Functional genomics
gnomAD constraint: pLI 8.18e-08, LOEUF 1.06, missense Z -0.344 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000295131 — one region, missense o/e 1.06.
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | zswim2 | ENSDARG00000075700 |
| mus_musculus | Zswim2 | ENSMUSG00000034552 |
| rattus_norvegicus | Zswim2 | ENSRNOG00000032579 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Arabidopsis thaliana | F4HZZ4 | 82.7% | Diamond |
| Oryza sativa Japonica Group | Q10R93 | 69.1% | Diamond |
| Schizosaccharomyces pombe 972h- | Q9P7E1 | 58.7% | Diamond |
| Encephalitozoon cuniculi GB-M1 | Q8SV35 | 58.1% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| CALCRL | protein-coding | 10203 |
| FAM171B | protein-coding | 165215 |
| TFPI | protein-coding | 7035 |
| CALCRL-AS1 | ncRNA | 105373786 |
| ITGAV | protein-coding | 3685 |
Protein
Protein identifiers
E3 ubiquitin-protein ligase ZSWIM2 — Q8NEG5 (reviewed: Q8NEG5)
Alternative names: MEKK1-related protein X, RING-type E3 ubiquitin transferase ZSWIM2, ZZ-type zinc finger-containing protein 2, Zinc finger SWIM domain-containing protein 2
All UniProt accessions (2): Q8NEG5, F8WCC6
UniProt curated annotations — full annotation on UniProt →
Function. E3 ubiquitin-protein ligase involved in the regulation of Fas-, DR3- and DR4-mediated apoptosis. Functions in conjunction with the UBE2D1, UBE2D3 and UBE2E1 E2 ubiquitin-conjugating enzymes.
Subunit / interactions. Dimer. Interacts with UBE2D1.
Tissue specificity. Expression is testis-specific.
Post-translational modifications. Polyubiquitinated. Polyubiquitination is followed by degradation via the proteasome.
Domain organisation. The SWIM-type zinc finger is required for ubiquitination activity.
RefSeq proteins (1): NP_872327* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000433 | Znf_ZZ | Domain |
| IPR001841 | Znf_RING | Domain |
| IPR007527 | Znf_SWIM | Domain |
| IPR013083 | Znf_RING/FYVE/PHD | Homologous_superfamily |
| IPR039903 | Zswim2 | Family |
| IPR043145 | Znf_ZZ_sf | Homologous_superfamily |
Pfam: PF00569, PF04434, PF13639
UniProt features (27 total): binding site 8, sequence conflict 7, strand 5, zinc finger region 4, helix 2, chain 1
Structure
Experimental structures (PDB)
1 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 2DIP | Solution structure of the ZZ domain of Zinc finger SWIM domain containing protein 2 | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NEG5-F1 | 63.82 | 0.36 |
Human Protein Atlas
Protein class: Enzymes, ENZYME proteins, Transferases, Metabolic proteins, Predicted intracellular proteins, Plasma proteins
Protein evidence: Evidence at protein level
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (8)
| Position | Role |
|---|---|
| 261 | Zn(2+) |
| 267 | Zn(2+) |
| 270 | Zn(2+) |
| 234 | Zn(2+) |
| 237 | Zn(2+) |
| 249 | Zn(2+) |
| 252 | Zn(2+) |
| 258 | Zn(2+) |
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 57 (showing top):
GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY, GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS, GOBP_APOPTOTIC_SIGNALING_PATHWAY, GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY, GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_PROTEIN_POLYUBIQUITINATION, MYB_Q3, GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY, GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS, GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY, MYB_Q5_01, GOBP_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY
GO Biological Process (2): protein polyubiquitination (GO:0000209), apoptotic process (GO:0006915)
GO Molecular Function (5): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), ubiquitin-protein transferase activity (GO:0004842), transferase activity (GO:0016740), metal ion binding (GO:0046872)
GO top-level categories
10 GO namespaces:
| Category | Terms |
|---|---|
| protein ubiquitination | 1 |
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| transition metal ion binding | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein ligase activity | 1 |
| ubiquitin-like protein transferase activity | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
showing 15 of 668 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZSWIM2 | RNF148 | Q8N7C7 | 583 |
| ZSWIM2 | CCDC146 | Q8IYE0 | 530 |
| ZSWIM2 | RNF151 | Q2KHN1 | 529 |
| ZSWIM2 | TSNAXIP1 | Q2TAA8 | 497 |
| ZSWIM2 | RSPH14 | Q9UHP6 | 481 |
| ZSWIM2 | OXNAD1 | Q96HP4 | 467 |
| ZSWIM2 | ZSWIM7 | Q19AV6 | 466 |
| ZSWIM2 | RSPH10B | P0C881 | 461 |
| ZSWIM2 | SCP2D1 | Q9UJQ7 | 457 |
| ZSWIM2 | TRIML1 | Q8N9V2 | 446 |
| ZSWIM2 | SLC66A1 | Q6ZP29 | 436 |
| ZSWIM2 | CFAP161 | Q6P656 | 430 |
| ZSWIM2 | LRRC23 | Q53EV4 | 421 |
| ZSWIM2 | RNF150 | Q9ULK6 | 420 |
| ZSWIM2 | RNF133 | Q8WVZ7 | 410 |
IntAct
Human interaction partners of ZSWIM2 in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
5 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| SEMG1 | association | 0.530 | 2 |
| EZR | physical association | 0.400 | 1 |
| ECE1 | physical association | 0.370 | 1 |
| MAGEA11 | physical association | 0.370 | 1 |
| UBE2U | physical association | 0.370 | 1 |
BioGRID (16 interactions; top human partners by supporting records): BCAM (Affinity Capture-MS; 2 records), LRFN4 (Affinity Capture-MS; 2 records), RNASE7 (Affinity Capture-MS; 2 records), SEMG1 (Affinity Capture-MS; 2 records), TKTL2 (Affinity Capture-MS; 2 records), C16orf72 (Positive Genetic), CSK (Synthetic Lethality), EZR (Cross-Linking-MS (XL-MS)), MAGEA11 (Two-hybrid), SET (Cross-Linking-MS (XL-MS)), UBE2U (Two-hybrid)
SIGNOR signaling
5 signaling interactions:
| A | Effect | B | Mechanism |
|---|---|---|---|
| Ub:E2 | “up-regulates activity” | ZSWIM2 | ubiquitination |
| UBE2D1 | “up-regulates activity” | ZSWIM2 | binding |
| UBE2E1 | “up-regulates activity” | ZSWIM2 | binding |
| ZSWIM2 | up-regulates | Apoptosis | |
| UBE2D3 | “up-regulates activity” | ZSWIM2 | binding |
Disease & clinical
Genetic variants
Variant evidence for ZSWIM2: 85 ClinVar records (0 pathogenic / likely pathogenic); 5 GWAS associations.
ClinVar
85 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 77 |
| Likely benign | 4 |
| Benign | 1 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 32 predictions of 720):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 2:186837317 | donor_gain | 1.0000 | |
| 2:186828792 | acceptor_gain | 0.9900 | |
| 2:186838957–186838958 | donor_loss | 0.9900 | 5 |
| 2:186839170–186839171 | acceptor_loss | 0.9900 | 6 |
| 2:186847717–186847718 | donor_loss | 0.9900 | 5 |
| 2:186847796–186847797 | acceptor_loss | 0.9900 | 6 |
| 2:186848788 | donor_gain | 0.9900 | |
| 2:186848995 | donor_gain | 0.9900 | |
| 2:186849052 | donor_gain | 0.9900 | |
| 2:186828791–186828792 | acceptor_loss | 0.9800 | 5 |
AlphaMissense
629 missense substitutions predicted likely pathogenic (of 4,208 scored), across 171 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| H173 | 8 | 0.878 | 0.963 |
| H367 | 8 | 0.876 | 0.947 |
| H78 | 8 | 0.838 | 0.954 |
| H364 | 8 | 0.829 | 0.943 |
| C164 | 7 | 0.967 | 0.984 |
| C147 | 7 | 0.958 | 0.986 |
| C234 | 7 | 0.955 | 0.978 |
| C344 | 7 | 0.955 | 0.983 |
| C150 | 7 | 0.953 | 0.975 |
| C194 | 7 | 0.946 | 0.991 |
| C176 | 7 | 0.944 | 0.981 |
| C197 | 7 | 0.936 | 0.970 |
| C382 | 7 | 0.933 | 0.972 |
| C64 | 7 | 0.931 | 0.962 |
| C347 | 7 | 0.929 | 0.963 |
| C168 | 7 | 0.928 | 0.965 |
| F366 | 7 | 0.920 | 0.985 |
| C76 | 7 | 0.907 | 0.950 |
| C362 | 7 | 0.905 | 0.955 |
| C370 | 7 | 0.904 | 0.947 |
HPA cancer prognostics
RNA cancer specificity: Not detected
Disease associations
OMIM: gene `` | disease phenotypes:
GWAS associations
5 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST006624_24 | Systolic blood pressure | 1e-11 |
| GCST90020026_588 | Hip index | 2e-9 |
| GCST90020029_894 | Waist circumference adjusted for body mass index | 1e-8 |
| GCST90020025_100 | Waist-to-hip ratio adjusted for BMI | 3e-8 |
| GCST90020029_893 | Waist circumference adjusted for body mass index | 4e-8 |
EFO canonical traits (from GWAS)
4 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0006335 | systolic blood pressure |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008039 | BMI-adjusted hip circumference |
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| semilicoisoflavone B | decreases phosphorylation | 1 |
| Arsenic | increases methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Lead | affects methylation | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.